Evidence map›Paper›PMID 35488952›Full record

ArticleApplied biochemistry and biotechnology2022

Water-Based Synthesis of Copper Chalcogenide Structures and Their Photodynamic Immunomodulatory Activities on Mammalian Macrophages.

Furkan Ayaz, Suleyman Gokhan Colak, Kasim Ocakoglu

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Furkan Ayaz *Department of Biotechnology, Faculty of Arts and Science, Mersin University, 33110, Mersin, Turkey. furkanayaz@mersin.edu.tr.ORCID http://orcid.org/0000-0003-0271-0594
Suleyman Gokhan ColakAdvanced Technology Research & Application Center, Mersin University, Ciftlikkoy Campus, TR33343, Yenisehir, Mersin, Turkey.
Kasim Ocakoglu *Department of Natural and Mathematical Sciences, Faculty of Engineering, Tarsus University, 33400, Tarsus, Turkey. kasim.ocakoglu@tarsus.edu.tr.ORCID http://orcid.org/0000-0003-2807-0425
Mersin Üniversitesi · TRTarsus University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generation of novel and versatile immunomodulatory agents that could suppress excessive inflammation has been crucial to fight against chronic inflammatory and autoimmune disorders. Immunomodulatory agents regulate the function of immune system cells to manage their activities. Current therapy regimens for the inflammatory and autoimmune disorders rely on immunomodulatory drug molecules but they are also associated with unwanted and severe side effects. In order to prevent the side effects associated with drug molecules, the field should generate novel immunomodulatory drug candidates and further test them. Moreover, the generation of photodynamic immunomodulatory molecules would also decrease possible side effects. Photodynamic activation enables specific and localized activation of the active ingredients upon exposure to a certain wavelength of light. In our study, we generated copper-based chalcogenide structures in gel and nanoparticle form by using a water-based method so that they are more biocompatible.After their chemical characterization, they were tested on mammalian macrophages in vitro. Our results suggest that these molecules were anti-inflammatory in dark conditions and their anti-inflammatory potentials significantly increased upon xenon light treatment. We are presenting novel photodynamic immunomodulatory agents that can be used to suppress excessive inflammation in disease conditions that have been associated with excessive inflammation.

Indexed as

Autoimmune DiseasesCopperAnimalsAnti-Inflammatory AgentsInflammationMacrophagesMammalsWaterAnti-Inflammatory AgentsCopperWaterChalcogenideCZTSImmunomodulatory drugsInflammationMacrophagesPhotodynamic therapy

Identifiers

PMID35488952
OpenAlexW4225153488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.